Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Anti-tumor Immunity and Improve Immunotherapy Efficacy.
Laight BJ, Harper D, Dmytryk N, Zhang CS, Shi C, Garven A, Nauman RW, Kment J, Alotaibi F, Shapovalov I, Hoskin V, Gao Y, Mewburn J, Vlasschaert C, Wang A, Simonetti J, LeBrun D, Tyryshkin K, Berman DM, Simpson AL, Graham CH, Craig AW, Basta S, Koti M, Greer PA.
Laight BJ, et al. Among authors: zhang cs.
Cancer Res. 2025 Apr 29. doi: 10.1158/0008-5472.CAN-24-3686. Online ahead of print.
Cancer Res. 2025.
PMID: 40299778